Growth of Biopharmaceutical Contract Manufacturing Organizations in China: An In-depth Study of Emerging Opportunities
BioPlan Associates’ report on the China Contract Manufacturing Organizations (CMOs) industry cover regional industry developments, regulatory and legal changes, and reviews China’s major CMO and CDMO companies with facility information, company ownership, background, management and facility capacity and history. This study is based on in-depth research, using public secondary and primary information resources. This is an on-going project that will be updated in the future to provide trends information, and relevant new in-depth insights into the rapidly growing and changing Chinese biologics industry.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook